Andrew Cutler, MD, says real-world MDD patients respond to adjunctive cariprazine like trial participants, with gains in mood and function within weeks.
Andrew J. Cutler, MD
Advertisement
Andrew J. Cutler, MD, clinical professor of psychiatry at SUNY Upstate Medical University.
Articles by Andrew J. Cutler, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Half-Life vs. Real Life: How Real-World Evidence Is Reframing Wet AMD Treatment
2
FAQ: What the Expanded Marstacimab Approval Means for Hemophilia A, B
3
Q&A: Zasocitinib Response in the Scalp, Nails, Palms and Soles
4
FDA Updates Sotatercept Label with HYPERION Data in Early PAH
5